How Knowledge Graphs Will Transform Data Management And Business

In late November the U.S. Federal Drug Administration approved Benevolent AI's recommended arthritis drug Baricitnib as a COVID-19 treatment, just nine-months after the hypothesis was developed. The correlation between the properties of this existing Eli Lilly drug and a potential treatment for seriously ill COVID-19 patients, was made with the help of knowledge graphs, which represent data in context, in a manner that humans and machines can readily understand. Knowledge graphs apply semantics to give context and relationships to data, providing a framework for data integration, unification, analytics and sharing. Think of them as a flexible means of discovering facts and relationships between people, processes, applications and data, in ways that give companies new insights into their businesses, create new services and improve R&D research. Benevolent AI, a six-year-old London-based company which has developed a platform of computational and experimental technologies and processes that can draw on vast quantities of biomedical data to advance drug development, built-in the use of knowledge graphs from day one.